DaVita Inc. logo

DaVita Inc. (DVA)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
187. 31
-1.85
-0.978%
$
12.07B Market Cap
16.41 P/E Ratio
- Div Yield
505,300 Volume
7.83 Eps
$ 189.16
Previous Close
Add Transaction
Day Range
186.54 189.91
Year Range
101 247.49
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors

DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors

DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close.

Zacks | 1 year ago
DaVita Says Ransomware Attack Affecting Some Operations

DaVita Says Ransomware Attack Affecting Some Operations

DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.

Wsj | 1 year ago
Dialysis firm DaVita hit by ransomware attack

Dialysis firm DaVita hit by ransomware attack

DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.

Reuters | 1 year ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know

DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know

The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close.

Zacks | 1 year ago
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day.

Zacks | 1 year ago
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors.

Zacks | 1 year ago
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) reachead $150.78 at the closing of the latest trading day, reflecting a +0.25% change compared to its last close.

Zacks | 1 year ago
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know

DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know

The latest trading day saw DaVita HealthCare (DVA) settling at $149.83, representing a +0.31% change from its previous close.

Zacks | 1 year ago
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) closed the most recent trading day at $141.12, moving -1.06% from the previous trading session.

Zacks | 1 year ago
Here's why this Warren Buffett stock plunged 11% in a day

Here's why this Warren Buffett stock plunged 11% in a day

Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings outlook, citing rising patient care costs, supply constraints, and ongoing dialysis center closures.

Finbold | 1 year ago
Why DaVita Inc Stock Is Plummeting Today

Why DaVita Inc Stock Is Plummeting Today

Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day.

Fool | 1 year ago
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.

Marketwatch | 1 year ago
Loading...
Load More